AI Article Synopsis

  • Cervicogenic headache (CEH) and occipital neuralgia (ON) are types of headaches that originate from the neck and often have overlapping symptoms, making diagnosis challenging and reliant on headache history and physical examinations.
  • A literature review from 2015 to August 2022 highlights various conservative and interventional treatments, including pain education, physical therapy, medication, nerve blocks, and advanced techniques like radiofrequency ablation and occipital nerve stimulation for chronic cases.
  • Ultimately, radiofrequency treatment is preferred for CEH, while pulsed radiofrequency is recommended for ON, with occipital nerve stimulation as an option for difficult cases.

Article Abstract

Introduction: Cervicogenic headache (CEH) and occipital neuralgia (ON) are headaches originating in the occiput and that radiate to the vertex. Because of the intimate relationship between structures based in the occiput and those in the upper cervical region, there is significant overlap between the presentation of CEH and ON. Diagnosis starts with a headache history to assess for diagnostic criteria formulated by the International Headache Society. Physical examination evaluates range of motion of the neck and the presence of tender areas or pressure points.

Methods: The literature for the diagnosis and treatment of CEH and ON was searched from 2015 through August 2022, retrieved, and summarized.

Results: Conservative treatment includes pain education and self-care, analgesic medication, physical therapy (such as reducing secondary muscle tension and improving posture), the use of TENS (transcutaneous electrical nerve stimulation), or a combination of the aforementioned treatments. Injection at various anatomical locations with local anesthetic with or without corticosteroids can provide pain relief for a short period. Deep cervical plexus block can result in improved pain for less than 6 months. In both CEH and ON, an occipital nerve block can provide important diagnostic information and improve pain in some patients, with PRF providing greater long-term pain control. Radiofrequency ablation of the cervical facet joints can result in improvement for over 1 year. Occipital nerve stimulation (ONS) should be considered for the treatment of refractory ON.

Conclusion: The treatment of CEH preferentially consists of radiofrequency treatment of the facet joints, while for ON, pulsed radiofrequency of the occipital nerves is indicated. For refractory cases, ONS may be considered.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11680101PMC
http://dx.doi.org/10.1111/papr.13405DOI Listing

Publication Analysis

Top Keywords

cervicogenic headache
8
occipital neuralgia
8
ceh occipital
8
treatment ceh
8
nerve stimulation
8
occipital nerve
8
facet joints
8
ons considered
8
occipital
5
ceh
5

Similar Publications

Structural Magnetic Resonance Imaging of Post-Traumatic Headache: A Systematic Review.

Curr Pain Headache Rep

January 2025

Department of Neurology, Danish Headache Center, Copenhagen University Hospital - Rigshospitalet, Valdemar Hansens Vej 5, Entrance 1A, 2600 Glostrup, Copenhagen, Denmark.

Purpose Of Review: To evaluate the available studies on structural magnetic resonance imaging (MRI) of post-traumatic headache (PTH).

Recent Findings: A systematic search of PubMed and Embase databases (from inception to February 1, 2024) identified nine relevant structural MRI studies. These studies included adult participants diagnosed with acute or persistent PTH in adherence with any edition of the International Classification of Headache Disorders.

View Article and Find Full Text PDF

The Dual Burden of Post-Traumatic Headache: Health Consequences and Economic Impact.

Curr Pain Headache Rep

January 2025

Department of Neurology, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, USA.

Purpose Of Review: To review the history and impact and burden of post-traumatic headache (PTH).

Recent Findings: PTH is a prevalent headache disorder that many healthcare providers encounter. Unlike more extensively researched primary headache disorders like migraines, PTH has not been as thoroughly studied, and there are fewer treatments specifically tested for it.

View Article and Find Full Text PDF

The COVID-19 pandemic has a profound and lasting impact on the mental health of recovered individuals. To investigate the clinical risk factors associated with long-term post-traumatic stress symptoms (PTSS), anxiety, and depression in COVID-19 survivors, demographic information and medical records were collected during February 19 and March 20, 2020. Assessments of PTSS, anxiety, and depressive symptoms were conducted at two months (April to May 2020, Session 1) and two years (April to May 2022, Session 2) post-discharge.

View Article and Find Full Text PDF

Objective: The objective of the study is to compare and investigate the combined and individual effects of workstation ergonomics, physiotherapy and patient education in improving CgH headaches and work ability in office workers.

Methods: 96 eligible CgH participants were divided into the ergonomics modifications group (EMG;  = 24), physiotherapy group (PTG;  = 24), and ergonomics modifications combined with physiotherapy group (EPG;  = 24) and education control group (CNG;  = 24), the participants received the respective treatment for 4 weeks. Primary (CgH frequency) and secondary (CgH pain intensity, CgH disability, flexion rotation test (right and left), neck disability index and work ability) scores were measured.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on the use of botulinum toxin, particularly onabotulinum toxin A (OTA), for treating migraine and post-traumatic headache (PTH) in military personnel and veterans.
  • The unique challenges faced by this population, including increased pain intensity and longer headache durations due to combat-related trauma, highlight the need for effective headache management strategies.
  • The literature review identified 8 relevant studies, mainly from the U.S., indicating that chronic migraine is the most common diagnosis treated with botulinum toxin, suggesting its effectiveness for preventing such conditions in service members.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!